Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Marisol S. Castaneto(University of Maryland, Baltimore), Marilyn A. Huestis(Smithsonian Institution), Rebecca L. Hartman(University of Maryland, Baltimore), Sandrine Pirard(National Institute on Drug Abuse), Nathalie A. Desrosiers(University of Maryland, Baltimore), David A. Gorelick(University of Maryland, Baltimore)
Cited by 697
Related Papers
Human Cannabinoid Pharmacokinetics
|Chemistry & Biodiversity|2007|1.1k
Neuropsychological Performance in Long-term Cannabis Users
|Archives of General Psychiatry|2001|656
Cannabis Effects on Driving Skills
|Clinical Chemistry|2012|613
Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid
|Journal of the American Society for Mass Spectrometry|2003|599
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
|Molecular Psychiatry|2011|582